Biogen Shares Plunge After FDA Says No Alzheimer's Treatment
Biogen stock plunges more than 30% after a Food and Drug Administration panel committee rules against giving the company's Alzheimer's drug the nod.
Biogen Alzheimer's drug closer to approvalBiogen has shown "exceptionally persuasive" evidence that its experimental Alzheimer's disease drug is effective, U.S. Food and Drug Administration staff said on Wednesday, elevating its chances of a..
![Biogen Alzheimer's drug closer to approval [Video]](https://video.newsserve.net/300/v/20201104/2011042043-Biogen-Alzheimer-drug-closer-to-approval.jpg)
